在ADHD自我治疗中使用新兴兴奋剂:混合方法分析
Tayler Holborn1, Fabrizio Schifano2, Emma Smith1
1Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London SE5 8AF, UK.
当治疗机会有限时,ADHD患者会使用新兴兴奋剂 (NPS) 进行自我治疗. 这些NPS被认为是有效的,突出了当前ADHD护理的差距.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 注意缺陷/多动障碍 (ADHD) 影响了许多人.
- 药物治疗是主要的治疗方法,但对于一些人来说,获得药物的机会是有限的.
- 用新型精神活性物质 (NPS) 治疗ADHD的自我治疗日益令人担忧.
研究的目的:
- 调查NPS用于自我治疗ADHD的使用情况.
- 评估NPSs的感知有效性.
- 探索用户体验和自我治疗的动机.
主要方法:
- 在线调查,有225名受访者.
- 与9名参与者进行半结构面试.
- 定性和定量数据的框架分析.
主要成果:
- 4F-MPH和2-FMA是最常用的NPSs.
- 自我治疗被认为比传统治疗更有效 (p < 0.001).
- 关键主题:作为治疗差距的NPS,治疗机会差,对医疗服务提供者的不信任.
结论:
- 对ADHD的NPS使用与限制对常规治疗的准入有关.
- 干预措施应解决治疗等待时间和地理障碍.
- 需要以患者为中心的护理和更广泛的药物治疗选择.
更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
